Stéphane Larochelle

Stéphane Larochelle

Auto-generated profile, based on publicly available information

Stéphane Larochelle

Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, New York, USA

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2012 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
PDF file
SLStéphane Larochelle
Stéphane Larochelle
RARamon Amat
Ramon Amat
KGKira Glover-Cutter
Kira Glover-Cutter
MSMiriam Sansó
Miriam Sansó
CZChao Zhang
Chao Zhang
RFRobert P Fisher
Robert P Fisher
RNA polymerase II (pol II) frequently pauses in the promoter-proximal region to ensure gene-specific regulation and RNA quality control. New research demonstrates that the cyclin-dependent kinase Cdk7 can act to establish the promoter-proximal pause, through its control of the TFIIE-DSIF switch, and to release Pol II from the pause, through its ability to activate Cdk9. Promoter-proximal pausing by RNA polymerase II (Pol II) ensures gene-specific regulation and RNA quality control. Structural considerations suggested a requirement for initiation-factor eviction in elongation-factor engagement and pausing of transcription complexes. Here we show that selective inhibition of Cdk7—part of TFIIH—increases TFIIE retention, prevents DRB sensitivity–inducing factor (DSIF) recruitment and attenuates pausing in human cells. Pause release depends on Cdk9–cyclin T1 (P-TEFb); Cdk7 is also required for Cdk9-activating phosphorylation and Cdk9-dependent downstream events—Pol II C-terminal domain Ser2 phosphorylation and histone H2B ubiquitylation—in vivo. Cdk7 inhibition, moreover, impairs Pol II transcript 3′-end formation. Cdk7 thus acts through TFIIE and DSIF to establish, and through P-TEFb to relieve, barriers to elongation: incoherent feedforward that might create a window to recruit RNA-processing machinery. Therefore, cyclin-dependent kinases govern Pol II handoff from initiation to elongation factors and cotranscriptional RNA maturation.

1 October 2009 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
KGKira Glover-Cutter
Kira Glover-Cutter
SLStéphane Larochelle
Stéphane Larochelle
BEBenjamin Erickson
Benjamin Erickson
CZChao Zhang
Chao Zhang
KSKevan Shokat
Kevan Shokat
DBDavid L. Bentley
David L. Bentley
The function of human TFIIH-associated Cdk7 in RNA polymerase II (Pol II) transcription and C-terminal domain (CTD) phosphorylation was investigated in analogue-sensitive Cdk7as/as mutant cells where the kinase can be inhibited without disrupting TFIIH. We show that both Cdk7 and Cdk9/PTEFb contribute to phosphorylation of Pol II CTD Ser5 residues on transcribed genes. Cdk7 is also a major kinase of CTD Ser7 on Pol II at the c-fos and U snRNA genes. Furthermore, TFIIH and recombinant Cdk7-CycH-Mat1 as well as recombinant Cdk9-CycT1 phosphorylated CTD Ser7 and Ser5 residues in vitro. Inhibition of Cdk7 in vivo suppressed the amount of Pol II accumulated at 5′ ends on several genes including c-myc, p21, and glyceraldehyde-3-phosphate dehydrogenase genes, indicating reduced promoter-proximal pausing or polymerase “leaking” into the gene. Consistent with a 5′ pausing defect, Cdk7 inhibition reduced recruitment of the negative elongation factor NELF at start sites. A role of Cdk7 in regulating elongation is further suggested by enhanced histone H4 acetylation and diminished histone H4 trimethylation on lysine 36—two marks of elongation—within genes when the kinase was inhibited. Consistent with a new role for TFIIH at 3′ ends, it was detected within genes and 3′-flanking regions, and Cdk7 inhibition delayed pausing and transcription termination.

13 March 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MBMark Burkard
Mark Burkard
CRCatherine L. Randall
Catherine L. Randall
SLStéphane Larochelle
Stéphane Larochelle
CZChao Zhang
Chao Zhang
KSKevan M. Shokat
Kevan M. Shokat
PJPrasad V. Jallepalli
Prasad V. Jallepalli
Polo-like kinases (Plks) play crucial roles in mitosis and cell division. Whereas lower eukaryotes typically contain a single Plk, mammalian cells express several closely related but functionally distinct Plks. We describe here a chemical genetic system in which a single Plk family member, Plk1, can be inactivated with high selectivity and temporal resolution by using an allele-specific, small-molecule inhibitor, as well as the application of this system to dissect Plk1's role in cytokinesis. To do this, we disrupted both copies of the PLK1 locus in human cells through homologous recombination and then reconstituted Plk1 activity by using either the wild-type kinase (Plk1 wt ) or a mutant version whose catalytic pocket has been enlarged to accommodate bulky purine analogs (Plk1 as ). When cultured in the presence of these analogs, Plk1 as cells accumulate in prometaphase with defects that parallel those found in PLK1 Δ/Δ cells. In addition, acute treatment of Plk1 as cells during anaphase prevents recruitment of both Plk1 itself and the Rho guanine nucleotide exchange factor (RhoGEF) Ect2 to the central spindle, abolishes RhoA GTPase localization to the equatorial cortex, and suppresses cleavage furrow formation and cell division. Our studies define and illuminate a late mitotic function of Plk1 that, although difficult or impossible to detect in Plk1-depleted cells, is readily revealed with chemical genetics.

1 March 2007 in Molecular Cell
Verified
Journal Article
Closed access
SLStéphane Larochelle
Stéphane Larochelle
KMKarl A. Merrick
Karl A. Merrick
MTMarie-Emilie Terret
Marie-Emilie Terret
LWLara Wohlbold
Lara Wohlbold
NBNora M. Barboza
Nora M. Barboza
RFRobert P. Fisher
Robert P. Fisher

1 February 1998 in Genes & Development
Verified
Journal Article
Open access
PDF file
SLStéphane Larochelle
Stéphane Larochelle
JPJudit Pandur
Judit Pandur
RFRobert P. Fisher
Robert P. Fisher
HSHelen K. Salz
Helen K. Salz
BSBeat Suter
Beat Suter
Cdk7 has been shown previously to be able to phosphorylate and activate many different Cdks in vitro. However, conclusive evidence that Cdk7 acts as a Cdk-activating kinase (CAK) in vivo has remained elusive. Adding to the controversy is the fact that in the budding yeast Saccharomyces cerevisiae, CAK activity is provided by the CAK1/Civ1 protein, which is unrelated to Cdk7. Furthermore Kin28, the budding yeast Cdk7 homolog, functions not as a CAK but as the catalytic subunit of TFIIH. Vertebrate Cdk7 is also known to be part of TFIIH. Therefore, in the absence of better genetic evidence, it was proposed that the CAK activity of Cdk7 may be an in vitro artifact. In an attempt to resolve this issue, we cloned theDrosophila cdk7 homolog and created null and temperature-sensitive mutations. Here we demonstrate that cdk7is necessary for CAK activity in vivo in a multicellular organism. We show that cdk7 activity is required for the activation of both Cdc2/Cyclin A and Cdc2/Cyclin B complexes, and for cell division. These results suggest that there may be a fundamental difference in the way metazoans and budding yeast effect a key modification of Cdks.

16 July 2001 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
SLStéphane Larochelle
Stéphane Larochelle
JCJian Chen
Jian Chen
RKRonald Knights
Ronald Knights
JPJudit Pandur
Judit Pandur
PMPatrick Morcillo
Patrick Morcillo
RFRobert P. Fisher
Robert P. Fisher
Cyclin‐dependent kinase (CDK)7–cyclin H, the CDK‐activating kinase (CAK) and TFIIH‐associated kinase in metazoans can be activated in vitro through T‐loop phosphorylation or binding to the RING finger protein MAT1. Although the two mechanisms can operate independently, we show that in a physiological setting, MAT1 binding and T‐loop phosphorylation cooperate to stabilize the CAK complex of Drosophila . CDK7 forms a stable complex with cyclin H and MAT1 in vivo only when phosphorylated on either one of two residues (Ser164 or Thr170) in its T‐loop. Mutation of both phosphorylation sites causes temperature‐dependent dissociation of CDK7 complexes and lethality. Furthermore, phosphorylation of Thr170 greatly stimulates the activity of the CDK7–cyclin H–MAT1 complex towards the C‐terminal domain of RNA polymerase II without significantly affecting activity towards CDK2. Remarkably, the substrate‐specific increase in activity caused by T‐loop phosphorylation is due entirely to accelerated enzyme turnover. Thus phosphorylation on Thr170 could provide a mechanism to augment CTD phosphorylation by TFIIH‐associated CDK7, and thereby regulate transcription.